UBS Group’s Xylem XYL Stock Holding History

UBS Group’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-26,400	Closed	-$3.12M	–	11699
2026 Q2	$3.12M	Buy	+26,400	New	+$3.05M	﹤0.01%	4651
2026 Q1	–	Sell	-5,600	Closed	-$763K	–	11266
2025 Q4	$763K	Hold	5,600	–	–	﹤0.01%	5800
2025 Q3	$826K	Buy	+5,600	New	+$777K	﹤0.01%	5722
2025 Q2	–	Sell	-4,400	Closed	-$526K	–	10910
2025 Q1	$526K	Buy	+4,400	New	+$545K	﹤0.01%	5818
2024 Q3	–	Sell	-11,200	Closed	-$1.52M	–	10138
2024 Q2	$1.52M	Buy	+11,200	New	+$1.52M	﹤0.01%	4032
2018 Q1	–	Sell	-35,700	Closed	-$2.44M	–	8217
2017 Q4	$2.44M	Buy	+35,700	New	+$2.37M	﹤0.01%	3022
2015 Q1	–	Sell	-100	Closed	-$4K	–	9466
2014 Q4	$4K	Buy	+100	New	+$3.66K	﹤0.01%	9136

Other funds holding XYL

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $13B AUM 14.15% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $72.8B AUM 32.97% 1-Year Est. Return

UBS Group's XYL Position: Q3 2026 in Review

UBS Group reduced its Xylem (XYL) stake by 2.6% in Q3 2026, selling an estimated $4.19M and leaving 1,396,520 shares worth $141M. The position accounts for 0.02% of the portfolio, ranked #861.

UBS Group first reported a position in XYL in Q4 2014 and has held it in 48 quarters since. The position peaked at $235M in Q4 2024. 656 funds tracked by Wall St. Rank hold XYL as of Q3 2026.

UBS Group held 1,396,520 shares of Xylem worth $141M as of Q3 2026.
UBS Group sold 36,646 Xylem shares in Q3 2026, an estimated $4.19M.
Xylem made up 0.02% of UBS Group's portfolio in Q3 2026, its #861 holding.
UBS Group first reported a position in Xylem in Q4 2014 and has held it in 48 quarters since.
UBS Group's Xylem position peaked at $235M in Q4 2024.
656 funds tracked by Wall St. Rank held Xylem as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.